Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.74 | 3.86 | 1.12 |
Stocks | 97.26 | 97.26 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.50 | 21.19 |
Price to Book | 3.82 | 4.17 |
Price to Sales | 2.08 | 2.49 |
Price to Cash Flow | 16.59 | 17.33 |
Dividend Yield | 1.21 | 1.32 |
5 Years Earnings Growth | 13.52 | 13.72 |
Number of long holdings: 92
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.23 | 758.8 | +1.80% | |
Merck&Co | US58933Y1055 | 6.65 | 101.59 | +0.43% | |
Eli Lilly | US5324571083 | 6.37 | 790.61 | +4.72% | |
Thermo Fisher Scientific | US8835561023 | 4.96 | 513.16 | -0.20% | |
AstraZeneca | GB0009895292 | 3.84 | 10,492.0 | +0.17% | |
Elevance Health | US0367521038 | 3.63 | 401.46 | -1.51% | |
GSK plc | GB00BN7SWP63 | 3.19 | 1,338.00 | -0.63% | |
Boston Scientific | US1011371077 | 3.09 | 90.37 | +1.26% | |
UnitedHealth | US91324P1021 | 2.82 | 608.18 | +0.39% | |
Medtronic | IE00BTN1Y115 | 2.81 | 85.88 | +0.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder Global Equity Fund I Acc | 1.9B | 7.06 | 11.71 | 13.08 | ||
Schroder Global Equity Fund I Inc | 1.9B | 7.04 | 11.70 | 13.07 | ||
QEP Global Core Equity Fund A Acc | 150.42M | 16.46 | 10.83 | 12.36 | ||
QEP Global Core Equity Fund A Inc | 54.38M | 16.44 | 10.81 | 12.36 | ||
QEP Global Core Equity Fund X Acc | 650.86M | 16.72 | 11.16 | 12.71 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review